TY  - GEN
AU  - Said,S
AU  - Omar,K
AU  - Koetsawang,S
AU  - Kiriwat,O
AU  - Srisatayapan,Y
AU  - Kazi,A
AU  - Ajmal,F
AU  - Wynter,H H
AU  - Pretnar-Darovec,A
AU  - Benitez,I B
TI  - A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction
SN  - 0010-7824
PY  - 1987///0210
KW  - Adult
KW  - Amenorrhea
KW  - chemically induced
KW  - Blood Pressure
KW  - Body Weight
KW  - Clinical Trials as Topic
KW  - Contraceptive Agents, Female
KW  - Female
KW  - Humans
KW  - Medroxyprogesterone
KW  - administration & dosage
KW  - Medroxyprogesterone Acetate
KW  - Pregnancy
KW  - Random Allocation
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/0010-7824(86)90004-1
ER  -